CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,226,764 | -9.5% | 177,419 | +0.2% | 0.01% | 0.0% |
| Q2 2023 | $5,773,577 | +19.3% | 176,995 | +28.7% | 0.01% | +16.7% |
| Q1 2023 | $4,840,102 | -44.5% | 137,542 | -27.8% | 0.01% | -50.0% |
| Q4 2022 | $8,726,969 | -12.1% | 190,462 | -7.1% | 0.01% | -14.3% |
| Q3 2022 | $9,928,664 | +151.7% | 204,926 | +104.1% | 0.01% | +40.0% |
| Q2 2022 | $3,945,000 | +187.7% | 100,422 | +169.6% | 0.01% | +233.3% |
| Q1 2022 | $1,371,000 | -18.3% | 37,254 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $1,678,000 | +53.5% | 36,805 | +20.3% | 0.00% | +50.0% |
| Q3 2021 | $1,093,000 | +102.0% | 30,592 | +12.0% | 0.00% | +100.0% |
| Q2 2021 | $541,000 | -33.0% | 27,315 | -21.4% | 0.00% | -50.0% |
| Q1 2021 | $808,000 | -5.7% | 34,732 | -15.8% | 0.00% | 0.0% |
| Q4 2020 | $857,000 | -12.1% | 41,233 | -8.4% | 0.00% | 0.0% |
| Q3 2020 | $975,000 | +112.9% | 45,035 | +131.6% | 0.00% | +100.0% |
| Q2 2020 | $458,000 | +39.6% | 19,445 | -30.1% | 0.00% | 0.0% |
| Q1 2020 | $328,000 | +15.9% | 27,828 | +4.3% | 0.00% | 0.0% |
| Q4 2019 | $283,000 | +17.9% | 26,675 | +26.3% | 0.00% | 0.0% |
| Q3 2019 | $240,000 | +0.8% | 21,122 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $238,000 | +46.9% | 21,122 | +5.4% | 0.00% | – |
| Q1 2019 | $162,000 | +27.6% | 20,041 | 0.0% | 0.00% | – |
| Q4 2018 | $127,000 | -35.5% | 20,041 | 0.0% | 0.00% | – |
| Q3 2018 | $197,000 | +18.7% | 20,041 | 0.0% | 0.00% | – |
| Q2 2018 | $166,000 | +20.3% | 20,041 | +4.4% | 0.00% | – |
| Q1 2018 | $138,000 | -11.5% | 19,190 | 0.0% | 0.00% | – |
| Q4 2017 | $156,000 | -43.9% | 19,190 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $278,000 | +19.8% | 19,190 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $232,000 | +28.2% | 19,190 | +35.9% | 0.00% | – |
| Q1 2017 | $181,000 | +5.2% | 14,122 | 0.0% | 0.00% | – |
| Q4 2016 | $172,000 | +1.8% | 14,122 | -23.3% | 0.00% | – |
| Q3 2016 | $169,000 | -3.4% | 18,419 | 0.0% | 0.00% | – |
| Q2 2016 | $175,000 | +34.6% | 18,419 | 0.0% | 0.00% | – |
| Q1 2016 | $130,000 | -32.6% | 18,419 | 0.0% | 0.00% | – |
| Q4 2015 | $193,000 | +56.9% | 18,419 | 0.0% | 0.00% | – |
| Q3 2015 | $123,000 | -0.8% | 18,419 | 0.0% | 0.00% | – |
| Q2 2015 | $124,000 | -41.2% | 18,419 | -16.9% | 0.00% | – |
| Q1 2014 | $211,000 | +46.5% | 22,159 | 0.0% | 0.00% | – |
| Q4 2013 | $144,000 | -14.3% | 22,159 | 0.0% | 0.00% | – |
| Q3 2013 | $168,000 | – | 22,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |